Biochemical characterization of a novel L-asparaginase with low glutaminase activity from Rhizomucor miehei and its application in food safety and leukemia treatment

Applied and Environmental Microbiology

Volumn 80, Issue 5, 2014, Pages 1561-1569

  Huang, Linhua ^a   Liu, Yu ^a   Sun, Yan ^b   Yan, Qiaojuan ^a   Jiang, Zhengqiang ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b BEIHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; FUNGAL DNA; GLUTAMINASE; LECTIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; ENZYME STABILITY; ENZYMOLOGY; ESCHERICHIA COLI; FOOD SAFETY; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LEUKEMIA; METABOLISM; METHODOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PH; PROTEIN MULTIMERIZATION; RHIZOMUCOR; SEQUENCE HOMOLOGY; TEMPERATURE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ASPARAGINASE; CELL LINE, TUMOR; CELL SURVIVAL; CLONING, MOLECULAR; DNA, FUNGAL; ENZYME STABILITY; ESCHERICHIA COLI; FOOD SAFETY; GENE EXPRESSION; GLUTAMINASE; HUMANS; HYDROGEN-ION CONCENTRATION; LECTINS; LEUKEMIA; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEIN MULTIMERIZATION; RHIZOMUCOR; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; TEMPERATURE;

EID: 84894068222     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03523-13     Document Type: Article

References (37)

1. Eisele N, Linke D, Bitzer K, Na'amnieh S, Nimtz M, Berger RG. 2011. The first characterized asparaginase from a basidiomycete, Flammulina velutipes. Bioresour. Technol. 102:3316-3321. http://dx.doi.org/10.1016/j.biortech.2010.10.098.
2. Oza VP, Parmar PP, Patel DH, Subramanian RB. 2011. Cloning, expression and characterization of L-asparaginase from Withania somnifera L. for large scale production. 3 Biotech 1:21-26. http://dx.doi.org/10.1007/s13205-011-0003-y.
3. Sahu MK, Sivakumar K, Poorani E, Thangaradjou T, Kannan L. 2007. Studies on L-asparaginase enzyme of actinomycetes isolated from estuarine fishes. J. Environ. Biol. 28:465-474.
4. Anese M, Quarta B, Peloux L, Calligaris S. 2011. Effect of formulation on the capacity of L-asparaginase to minimize acrylamide formation in short dough biscuits. Food Res. Int. 44:2837-2842. http://dx.doi.org/10.1016/j.foodres.2011.06.025.
5. Hendriksen HV, Kornbrust BA, Ostergaard PR, Stringer MA. 2009. Evaluating the potential for enzymatic acrylamide mitigation in a range of food products using an asparaginase from Aspergillus oryzae. J. Agric. Food Chem. 57:4168-4176. http://dx.doi.org/10.1021/jf900174q.
6. Mahajan RV, Saran S, Kameswaran K, Kumar V, Saxena RK. 2012. Efficient production of L-asparaginase from Bacillus licheniformis with low-glutaminase activity: optimization, scale up and acrylamide degradation studies. Bioresour. Technol. 125:11-16. http://dx.doi.org/10.1016/j.biortech.2012.08.086.
7. Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, Otten J, Philippe N. 2002. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood 99:2734-2739. http://dx.doi.org/10.1182/blood.V99.8.2734.
8. Mottram DS, Wedzicha BL, Dodson AT. 2002. Acrylamide is formed in the Maillard reaction. Nature 419:448-449. http://dx.doi.org/10.1038/419448a.
9. Narta UK, Kanwar SS, Azmi W. 2007. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit. Rev. Oncol. Hematol. 61:208-221. http://dx.doi.org/10.1016/j.critrevonc.2006.07.009.
10. Geuenich S, Haberl C, Egger D, Kaspers U, Hültner L, Wilmanns W, Denzlinger C. 1998. Induction of leukotriene production by bleomycin and asparaginase in mast cells in vitro and in patients in vivo. Biochem. Pharmacol. 55:447-453. http://dx.doi.org/10.1016/S0006-2952(97)00481-4.
11. Kumar S, Venkata Dasu V, Pakshirajan K. 2011. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. Bioresour. Technol. 102:2077-2082. http://dx.doi.org/10.1016/j.biortech.2010.07.114.
12. Ferrara MA, Severino NMB, Valente RH, Perales J, Bon EPS. 2010. Highyield extraction of periplasmic asparaginase produced by recombinant Pichia pastoris harbouring the Saccharomyces cerevisiae ASP3 gene. Enzyme Microb. Technol. 47:71-76. http://dx.doi.org/10.1016/j.enzmictec.2010.05.001.
13. Sarquis MI, Oliveira EM, Santos AS, Costa GL. 2004. Production of L-asparaginase by filamentous fungi. Mem. Inst. Oswaldo Cruz 99:489-492. http://dx.doi.org/10.1590/S0074-02762004000500005.
14. Shrivastava A, Khan AA, Shrivastav A, Jain SK, Singhal PK. 2012. Kinetic studies of L-asparaginase from Penicillium digitatum. Prep. Biochem. Biotechnol. 42:574-581. http://dx.doi.org/10.1080/10826068.2012.672943.
15. Katrolia P, Jia HY, Yan QJ, Song S, Jiang ZQ, Xu HB. 2012. Characterization of a protease-resistant alpha-galactosidase from the thermophilic fungus Rhizomucor miehei and its application in removal of raffinose family oligosaccharides. Bioresour. Technol. 110:578-586. http://dx.doi.org/10.1016/j.biortech.2012.01.144.
16. Huang LH, Yan QJ, Kopparapu NK, Jiang ZQ, Sun Y. 2012. Astragalus membranaceus lectin (AML) induces caspase-dependent apoptosis in human leukemia cells. Cell Prolif. 45:15-21. http://dx.doi.org/10.1111/j.1365-2184.2011.00800.x.
17. Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Lodhi MA, Ye GN, Weeden NF, Reisch BI. 1994. A simple and efficient method for DNA extractions from grape vine cultivars and Vitis species. Plant Mol. Biol. Rep. 12:6-13. http://dx.doi.org/10.1007/BF02668658.
19. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. http://dx.doi.org/10.1038/227680a0.
20. Wade HE, Phillips BP. 1971. Automated determination of bacterial asparaginase and glutaminase. Anal. Biochem. 44:189-199. http://dx.doi.org/10.1016/0003-2697(71)90360-5.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
22. Anese M, Quarta B, Frias J. 2011. Modelling the effect of asparaginase in reducing acrylamide formation in biscuits. Food Chem. 126:435-440. http://dx.doi.org/10.1016/j.foodchem.2010.11.007.
23. Jiang ZQ, Li XT, Yang SQ, Li LT, Tan SS. 2005. Improvement of the breadmaking quality of wheat flour by the hyperthermophilic xylanase B from Thermotoga maritima. Food Res. Int. 38:37-43. http://dx.doi.org/10.1016/j.foodres.2004.07.007.
24. Moreno-Enriquez A, Evangelista-Martinez Z, Gonzalez-Mondragon EG, Calderon-Flores A, Arreguin R, Perez-Rueda E, Huerta-Saquero A. 2012. Biochemical characterization of recombinant L-asparaginase (AnsA) from Rhizobium etli, a member of an increasing rhizobial-type family of L-asparaginases. J. Microbiol. Biotechnol. 22:292-300. http://dx.doi.org/10.4014/jmb.1107.07047.
25. Tallman MS, Appelbaum FR, Amos D, Goldberg RS, Livingston RB, Mortimer J, Weiden PL, Thomas ED. 1987. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide. J. Clin. Oncol. 5:918-926.
26. Wang H, Geng QR, Wang L, Lu Y. 2012. Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia. Leukemia Lymphoma 53:1376-1382. http://dx.doi.org/10.3109/10428194.2011.649478.
27. Yun MK, Nourse A, White SW, Rock CO, Heath RJ. 2007. Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I. J. Mol. Biol. 369:794-811. http://dx.doi.org/10.1016/j.jmb.2007.03.061.
28. Tsuji N, Morales TH, Ozols VV, Carmody AB, Chandrashekar R. 1999. Identification of an asparagine amidohydrolase from the filarial parasite Dirofilaria immitis. Int. J. Parasitol. 29:1451-1455. http://dx.doi.org/10.1016/S0020-7519(99)00087-9.
29. Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. 1993. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc. Natl. Acad. Sci. U. S. A. 90:1474-1478. http://dx.doi.org/10.1073/pnas.90.4.1474.
30. Ito K, Matsushima K, Koyama Y. 2012. Gene cloning, purification, and characterization of a novel peptidoglutaminase-asparaginase from Aspergillus sojae. Appl. Environ. Microbiol. 78:5182-5188. http://dx.doi.org/10.1128/AEM.00765-12.
31. Kotzia GA, Labrou NE. 2007. L-Asparaginase from Erwinia chrysanthemi 3937: cloning, expression and characterization. J. Biotechnol. 127:657-669. http://dx.doi.org/10.1016/j.jbiotec.2006.07.037.
32. Pokrovskaya MV, Aleksandrova SS, Pokrovsky VS, Omeljanjuk NM, Borisova AA, Anisimova NY, Sokolov NN. 2012. Cloning, expression and characterization of the recombinant Yersinia pseudotuberculosis L-asparaginase. Protein Expr. Purif. 82:150-154. http://dx.doi.org/10.1016/j.pep.2011.12.005.
33. Mohan Kumar N, Manonmani HK. 2013. Purification, characterization and kinetic properties of extracellular L-asparaginase produced by Cladosporium sp. World J. Microbiol. Biotechnol. 29:577-587. http://dx.doi.org/10.1007/s11274-012-1213-0.
34. Broome JD. 1981. L-Asparaginase: discovery and development as a tumor-inhibitory agent. Cancer Treat. Rep. 65:111-114.
35. Ramya LN, Doble M, Rekha VP, Pulicherla KK. 2012. L-Asparaginase as potent anti-leukemic agent and its significance of having reduced glutaminase side activity for better treatment of acute lymphoblastic leukaemia. Appl. Biochem. Biotechnol. 167:2144-2159. http://dx.doi.org/10.1007/s12010-012-9755-z.
36. Saba CF, Hafeman SD, Vail DM, Thamm DH. 2009. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma. J. Vet. Intern. Med. 23:1058-1063. http://dx.doi.org/10.1111/j.1939-1676.2009.0357.x.
37. Wang L, Wang ZH, Chen XQ, Li YJ, Wang KF, Xia YF, Xia ZJ. 2013. First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. Cancer 119:348-355. http://dx.doi.org/10.1002/cncr.27752.